Historical record - last NADAC effective date: 7/21/2021

Product Information

MORPHINE SULF ER 200 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.5441 per EA under NDC 43386054401. Its NADAC has been published 265 times since Mar 15, 2017.

FDA first approved this application on Dec 16, 2015.

MORPHINE SULF ER 200 MG TABLET

Morphine Sulfate
$2.5441per EA
DEA Schedule CII

Strength

200 mg/1

NDC

43386054401

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

7/21/2021

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203602

FDA Approved

12/16/2015

On Market Since

12/16/2015

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for MORPHINE SULF ER 200 MG TABLET has been published 265 times since Mar 15, 2017, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.

Current price$2.5441 per EA
All-time high$3.7456 (Jun 13, 2018)
All-time low$1.7036 (Sep 18, 2019)
Median price$2.5680
Average price$2.6286
Largest weekly change+62.5% (Feb 19, 2020)
Weeks tracked265
Tracking sinceMar 15, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

0.0%

All

-28.0%

Last surveyed Apr 6, 2022 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 22%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of MORPHINE SULF ER 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF ER 200 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $2.5441 per EA (NDC 43386054401), effective Apr 6, 2022.

How has the price of MORPHINE SULF ER 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for MORPHINE SULF ER 200 MG TABLET has declined 28.0%. It has been tracked across 265 weekly CMS publications since Mar 15, 2017.

What are the highest and lowest recorded NADAC prices for MORPHINE SULF ER 200 MG TABLET?

Since Mar 15, 2017, the NADAC for MORPHINE SULF ER 200 MG TABLET has ranged from a low of $1.7036 (Sep 18, 2019) to a high of $3.7456 (Jun 13, 2018), with a median of $2.5680 per EA.

Are there cheaper alternatives to MORPHINE SULF ER 200 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MORPHINE SULF ER 200 MG TABLET, is $1.9746 per EA — about 22% below MORPHINE SULF ER 200 MG TABLET.

Who manufactures MORPHINE SULF ER 200 MG TABLET?

MORPHINE SULF ER 200 MG TABLET (NDC 43386054401) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.